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Division of labour between PP2A-B56
isoforms at the centromere and
kinetochore
Giulia Vallardi, Lindsey A Allan, Lisa Crozier, Adrian T Saurin*
Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee,
United Kingdom
Abstract PP2A-B56 is a serine/threonine phosphatase complex that regulates several major
mitotic processes, including sister chromatid cohesion, kinetochore-microtubule attachment and
the spindle assembly checkpoint. We show here that these key functions are divided between
different B56 isoforms that localise to either the centromere or kinetochore. The centromeric
isoforms rely on a specific interaction with Sgo2, whereas the kinetochore isoforms bind
preferentially to BubR1 and other proteins containing an LxxIxE motif. In addition to these selective
binding partners, Sgo1 helps to anchor PP2A-B56 at both locations: it collaborates with BubR1 to
maintain B56 at the kinetochore and it helps to preserve the Sgo2/B56 complex at the centromere.
A series of chimaeras were generated to map the critical region in B56 down to a small C-terminal
loop that regulates the key interactions and defines B56 localisation. Together, this study describes
how different PP2A-B56 complexes utilise isoform-specific interactions to control distinct processes
during mitosis.
DOI: https://doi.org/10.7554/eLife.42619.001
Introduction
Protein Phosphatase 2A (PP2A) is a major class of serine/threonine phosphatase that is composed of
a catalytic (C), scaffold (A) and regulatory (B) subunit. Substrate specificity is mediated by the regula-
tory B subunits, which can be subdivided into four structurally distinct families: B (B55), B’ (B56), B’
(PR72) and B’’ (Striatin) (Seshacharyulu et al., 2013).
In humans, the B subunits are encoded by a total of 15 separate genes which give rise to at least
26 different transcripts and splice variants; therefore, each of the four B subfamilies are composed
of multiple different isoforms (Seshacharyulu et al., 2013). Although these isoforms are thought to
have evolved to enhance PP2A specificity, there is still no direct evidence that isoforms of the same
subfamily can regulate specific pathways or processes. Perhaps the best indirect evidence that they
can comes from the observation that B56 isoforms localise differently during mitosis (Bastos et al.,
2014; Nijenhuis et al., 2014). However, even in these cases, it is still unclear how this differential
localisation is achieved or why it is needed.
We addressed this problem by focussing on prometaphase, a stage in mitosis when PP2A activity
is essential to regulate sister chromatid cohesion (Kitajima et al., 2006; Riedel et al., 2006;
Tang et al., 2006), kinetochore-microtubule attachments (Foley et al., 2011; Kruse et al., 2013;
Suijkerbuijk et al., 2012; Xu et al., 2013) and the spindle assembly checkpoint (Espert et al., 2014;
Nijenhuis et al., 2014). Crucially, all of these mitotic functions are controlled by PP2A-B56 com-
plexes that localise to either the centromere or the kinetochore.
The kinetochore is a multiprotein complex that assembles on centromeres to allow their physical
attachment to microtubules. This attachment process is stochastic and error-prone, and therefore it
is safeguarded by two key regulatory processes: the spindle assembly checkpoint (SAC) and
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kinetochore-microtubule error-correction. The SAC preserves the mitotic state until all kinetochores
have been correctly attached to microtubules, whereas the error-correction machinery removes any
faulty microtubule attachments that may form. The kinase Aurora B is critical for both processes
because it phosphorylates the kinetochore-microtubule interface to destabilise incorrectly attached
microtubules and it reinforces the SAC, in part by antagonising Knl1-PP1, a kinetochore phosphatase
complex needed for SAC silencing (Saurin, 2018). These two principal functions of Aurora B are
antagonised by PP2A-B56, which localises to the Knl1 complex at the outer kinetochore by binding
directly to BubR1 (Foley et al., 2011; Kruse et al., 2013; Suijkerbuijk et al., 2012; Xu et al., 2013).
This interaction is mediated by the B56 subunit, which interacts with a phosphorylated LxxIxE motif
within the kinetochore attachment regulatory domain (KARD) of BubR1 (Wang et al., 2016a;
Wang et al., 2016b).
As well as localising to the outer kinetochore, PP2A-B56 also localises to the centromere by bind-
ing to shugoshin 1 and 2 (Sgo1/Sgo2) (Kitajima et al., 2006; Riedel et al., 2006; Rivera et al.,
2012; Tang et al., 2006; Tanno et al., 2010; Xu et al., 2009). The crystal structure of Sgo1 bound
to PP2A-B56 has been solved to reveal a bipartite interaction between Sgo1 and the regulatory and
catalytic subunits of the PP2A-B56 complex (Xu et al., 2009). This interaction is thought to allow
centromere-localised PP2A-B56 to counteract various kinases, such as Aurora B, which remove cohe-
sin rings from chromosome arms during early mitosis in higher eukaryotes (Marston, 2015). The
result is that cohesin is specifically preserved at the centromere where it is needed to resist the
eLife digest The cells in our body are a hive of activity, but that activity must be kept under
control. This is never more critical than when a cell divides, because unchecked cell division can lead
to cancer. Fortunately, enzymes called kinases and phosphatases exist to control the countless
proteins in a cell; these enzymes help ensure that each step of cell division is complete before
moving on to the next.
Kinases control other proteins by adding bulky phosphate groups to them, while phosphatases
remove those groups. For a long time, phosphatases were assumed to be less specific than their
kinase counterparts. Yet it has now become clear that phosphatases achieve specificity by
interacting with a range of regulatory subunits.
A phosphatase called PP2A oversees a number of key steps in cell division by working together
with its regulatory B56 subunit. In human cells, there are five separate genes that encode B56
subunits, and all of these B56 ‘isoforms’ were thought to exert the same influence on the PP2A
phosphatase. The fact, however, that different isoforms are found at different locations within the
cell suggested otherwise.
To investigate this, Vallardi et al. focused on a particular stage of cell division when the activity of
the PP2A-B56 complex is essential. Before a cell divides it duplicates its genetic material and the
two copies of each chromosome are held together until the cell is ready to pull them apart. The
experiments compared two representative B56 isoforms: one that concentrates at the centromere,
the region where the copied chromosomes are held together; and another found at the kinetochore,
a nearby structure that is involved in pulling the two chromosomes apart. By eliminating all but one
isoform and measuring the ensuing activity of the PP2A-B56 complex, Vallardi et al. could
differentiate between the main regulatory roles of each isoform. These experiments showed that
B56 isoforms control separate processes during cell division, which mirrors their different locations
within the cell.
Next, Vallardi et al. looked at the receptor proteins that recruit each isoform to its position.
Removing or relocating different receptors showed how they anchor select B56 isoforms in different
positions while the associated PP2A enzymes get to work on different processes. Further
experiments using ‘hybrid’ subunits made from parts of two different B56 isoforms then helped to
reveal the site on the B56 subunits that determines which receptors they bind to. Together these
findings show that slight differences between each B56 isoform ultimately dictate where they
localise and what processes they control when cells divide.
DOI: https://doi.org/10.7554/eLife.42619.002
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pulling forces exerted by microtubules. As well as preserving cohesion at the centromere, PP2A-B56
is also thought to balance the net level of Aurora B activation in this region (Meppelink et al.,
2015).
In human cells, B56 isoforms are encoded by five separate genes (B56a, b, g, d and e). The inter-
action interfaces involved in BubR1 and Sgo1 binding are extremely well conserved between all of
these B56 isoforms (Figure 1—figure supplement 1). This explains why BubR1 and Sgo1 appear to
display no specificity for individual B56 isoforms (Kitajima et al., 2006; Kruse et al., 2013;
Riedel et al., 2006; Xu et al., 2013; Xu et al., 2009), and why these isoforms have been proposed
to function redundantly at kinetochores during mitosis (Foley et al., 2011).
However, one crucial observation throws doubt over this issue of redundancy: individual B56 iso-
forms localise differentially to either the kinetochore or centromere in human cells (Meppelink et al.,
2015; Nijenhuis et al., 2014). It is therefore not easy to reconcile this differential localisation with
the evidence presented above, which implies that the centromere and kinetochore receptors for B56
do not display any selectivity for individual isoforms. This caused us to readdress the question of
redundancy and isoform specificity in human cells.
Results
PP2A-B56 isoforms have specific roles at the centromere and
kinetochore during mitosis
PP2A-B56 isoform localisation to the centromere and kinetochore was visualised in nocodazole-
arrested HeLa Flp-in cells expressing YFP-tagged B56 subunits. This revealed that while some B56
isoforms localise predominantly to the sister kinetochore pairs marked by Cenp-C (B56g and d),
others localise mainly to the centromere defined by Sgo2 (B56a and e), and one isoform displayed a
mixed localisation pattern (B56b) (Figure 1a,b). B56 isoforms have been proposed to act redun-
dantly at the kinetochore in human cells (Foley et al., 2011), therefore we readdressed this question
in light of their differential localisation. B56a and B56g were chosen as representative members of
the centromere and kinetochore-localised pools, respectively, since these isoforms could both be
readily detected by western blot analysis of HeLa cell lysates (Figure 1—figure supplement 2). Fur-
thermore, both genes were endogenously tagged using CRISPR/Cas9-mediated homologous recom-
bination to demonstrate consistent expression and differential localisation to either the centromere
or kinetochore (Figure 1—figure supplement 3). All B56 isoforms were then depleted, except for
either B56a or B56g (Figure 1—figure supplement 2), to determine whether these endogenous iso-
forms could support centromere and kinetochore functions.
Centromeric PP2A-B56 is important for maintaining sister chromatid cohesion during mitosis in
human cells (Marston, 2015). In agreement with our differential localisation data, only the centro-
mere-localised B56a was able to support proper centromeric cohesion (Figure 1c). In fact, we
observed no difference in the extent of sister chromatid splitting when comparing loss of all B56 iso-
forms to a situation when only B56g is retained (Figure 1c). Therefore, sister chromatid cohesion can
be supported by a B56 isoform that localises primarily to the centromere (B56a), but not by one that
localises to the kinetochore (B56g ).
To examine which B56 isoforms can support kinetochore functions, we first focussed on SAC sig-
nalling. The SAC is activated at kinetochores by the phosphorylation of ‘MELT’ repeats on Knl1 by
the kinase Mps1 (London et al., 2012; Shepperd et al., 2012; Yamagishi et al., 2012). These phos-
phorylated repeats recruit a variety of SAC proteins to the kinetochore, which are then assembled
into an inhibitory complex that is released into the cytosol to prevent mitotic exit (Saurin, 2018).
PP2A-B56 antagonises this process, as evidenced by the fact that removal of B56 from kinetochores
prevents Knl1-MELT dephosphorylation and delays mitotic exit following Mps1 inhibition in nocoda-
zole (Espert et al., 2014; Nijenhuis et al., 2014). Therefore, we sought to address whether these
effects were dependent on specific B56 isoforms.
As expected, simultaneous depletion of all B56 isoforms enhanced basal Knl1-MELT phosphoryla-
tion in nocodazole, delayed MELT dephosphorylation upon Mps1 inhibition with AZ-3146
(Hewitt et al., 2010), and prevented mitotic exit under identical conditions (Figure 1d–f). Impor-
tantly, these effects were all rescued when endogenous B56g was preserved, but not if only B56a
remained (Figure 1d–f). Kinetochore PP2A-B56 also has well-established roles in chromosome
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Figure 1. A subset of PP2A-B56 complexes control spindle assembly checkpoint silencing and chromosome alignment. (A and B) Representative
images (A) and line plots (B) of nocodazole-arrested Flp-in HeLa cells expressing YFP-B56 (B56a, B56b, B56g1, B56g3, B56d and B56e). For line plots,
five kinetochore pairs were analysed per cell, for a total of 10 cells per experiment. Graphs represent the mean intensities (±SD) from 3 independent
experiments. Intensity is normalized to the maximum signal in each channel in each experiment. (C–G) Flp-in HeLa cells treated with siRNA against
Figure 1 continued on next page
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alignment where it is needed to antagonise Aurora B and allow initial kinetochore-microtubule
attachment to form (Foley et al., 2011; Kruse et al., 2013; Suijkerbuijk et al., 2012; Xu et al.,
2013). Knockdown of all B56 isoforms produced severe defects in chromosome alignment, as
expected, and these effects could be rescued by preserving B56g, but not B56a (Figure 1g). In sum-
mary, only the kinetochore-localised B56g , and not the centromeric B56a, can support SAC silencing
and chromosome alignment in human cells.
Overexpression of GFP-B56a has previously been shown to rescue kinetochore-microtubule
attachment defects following the depletion of all PP2A-B56 isoforms in human cells (Foley et al.,
2011). To understand the discrepancy with our data, we performed the same assays as previously,
but this time expressing siRNA-resistant YFP-B56a or YFP-B56g to rescue the knockdown of all
endogenous B56 isoforms. Under these conditions, both exogenous B56 isoforms were able to res-
cue MELT dephosphorylation, SAC silencing and chromosome alignment (Figure 1—figure supple-
ment 4). The ability of exogenous YFP-B56a to support kinetochore functions can be explained by
the fact that it is highly overexpressed, which leads to elevated centromere and kinetochore levels in
comparison to the endogenous YFP-B56a situation (Figure 1—figure supplement 5). We therefore
conclude B56a acts primarily at the centromere, but it can still function at the kinetochore when
overexpressed. In summary, under endogenous conditions, PP2A-B56 isoforms localise differentially
to the centromere or kinetochore where they carry out specific roles in sister chromatid cohesion,
SAC silencing and chromosomal alignment.
We next sought to determine the molecular explanation for differential B56 isoform localisation.
This was difficult to reconcile with existing structural data mapping the interaction between PP2A-
B56 and the reported kinetochore and centromere receptors - BubR1 and Sgo1 – since these dem-
onstrate that the key interacting residues are well conserved between all B56 isoforms (Figure 1—
figure supplement 1) (Wang et al., 2016a; Wang et al., 2016b; Xu et al., 2009). Furthermore, bio-
chemical studies could not detect a difference in association between different B56 isoforms and
either BubR1 or Sgo1 (Kitajima et al., 2006; Kruse et al., 2013; Xu et al., 2013). Therefore, we
decided to first test whether BubR1 or Sgo1 were the only receptors for B56 at the kinetochore and
centromere.
Figure 1 continued
B56pool, all B56 isoforms except B56a, or all B56 isoforms except B56g , were analysed for sister chromatid cohesion, SAC strength, Knl1-MELT
dephosphorylation and chromosomal alignment. (C) Quantification of percentage of chromosome spreads that contain at least one split centromere.
Graph represents mean data (+SD) from 3 independent experiments with 50 metaphase spreads quantified per condition per experiment. (D) Time-
lapse analysis of cells entering mitosis in the presence of nocodazole and 2.5 mM AZ-3146. The graph represents the cumulative data from 50 cells,
which is representative of 3 independent experiments. Representative images (E) and quantification (F) of relative kinetochore intensities of Knl1-pMELT
in cells arrested in prometaphase with nocodazole and treated with MG132 for 30 min, followed by 2.5 mM AZ-3146 for the indicated amount of time.
10 cells were quantified per experiment and the graph displays the mean (+SD) of 3 independent experiments. The individual data points for each
experiment can be found in the source data. (G) Quantification of chromosome misalignment in cells arrested in metaphase with MG-132. At least 100
cells were scored per condition per experiment and graph represents the mean (-SD) of 3 independent experiments. Misalignments were score as mild
(1 to 2 misaligned chromosomes), intermediate (3 to 5 misaligned chromosomes), and severe (>5 misaligned chromosomes). Asterisks indicate
significance (Figure 1c: Welch’s t -test, unpaired, Figure 1f: Mann-Whitney test); ns p>0.05, *p0.05, **p0.01, ****p0.0001. Scale bars, 5mm.
DOI: https://doi.org/10.7554/eLife.42619.003
The following figure supplements are available for figure 1:
Figure supplement 1. Alignment of B56 isoforms to show that Sgo1 and BubR1 interacting regions are conserved.
DOI: https://doi.org/10.7554/eLife.42619.004
Figure supplement 2. Western blot showing knockdown of different B56 isoforms.
DOI: https://doi.org/10.7554/eLife.42619.005
Figure supplement 3. Endogenous tagging of B56a and B56g with YFP confirms centromere and kinetochore localisation.
DOI: https://doi.org/10.7554/eLife.42619.006
Figure supplement 4. Overexpression of YFP-B56a can rescue kinetochore functions.
DOI: https://doi.org/10.7554/eLife.42619.007
Figure supplement 5. Overexpression of YFP-B56a enhances B56a levels at centromeres and kinetochores.
DOI: https://doi.org/10.7554/eLife.42619.008
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Sgo2 provides specificity for centromeric B56 recruitment
At the centromere, Sgo1 and Sgo2 can both bind to PP2A-B56 (Rivera et al., 2012; Tanno et al.,
2010; Xu et al., 2009), but Sgo1 is considered the primary receptor because it is more important
than Sgo2 for protecting cohesion in mitosis (Huang et al., 2007; Kitajima et al., 2005;
Kitajima et al., 2006; Llano et al., 2008; McGuinness et al., 2005; Rivera et al., 2012; Tang et al.,
2006; Tanno et al., 2010). However, this critical role in cohesin maintenance could also be explained
by PP2A- independent effects (Hara et al., 2014). Furthermore, although Sgo1 has been implicated
in PP2A-B56 recruitment to centromeres (Liu et al., 2013a; Liu et al., 2013b; Nishiyama et al.,
2013; Tang et al., 2006), the only study that has directly compared the contribution of Sgo1 and
Sgo2 to centromeric PP2A-B56 recruitment, has concluded that Sgo2 is more important
(Kitajima et al., 2006). We therefore set out to clarify the role of Sgo1 and Sgo2 in controlling the
recruitment of B56 isoforms to the centromere in human cells.
Depletion of Sgo2, but not Sgo1, caused a significant reduction in B56a levels at the centromere
(Figure 2a–d). It is important to note that the quantification in Figure 2b and d cannot distinguish
between kinetochore and centromere localisation, and whilst Sgo1 depletion did not reduce B56, it
did appear to shift its localisation towards the kinetochore (see zoom panel in Figure 2c), an effect
that has previously been seen by others (Meppelink et al., 2015). Line plots analysis, which can
quantify localisation across the centromere-kinetochore axis, demonstrates that Sgo1 depletion
caused Sgo2 and B56a to spread out from the centromere towards the kinetochore (Figure 2e).
This is due to inefficient anchoring of Sgo2 at centromeres because combined Sgo1 and Sgo2 deple-
tion completely removed B56a from kinetochores and centromeres (Figure 2f,g). We therefore con-
clude that, as suggested previously by others (Kitajima et al., 2006), Sgo2 is the primary
centromeric receptor for PP2A-B56 during mitosis. However, Sgo1 also contributes to centromeric
B56 localisation primarily by helping to anchor the Sgo2-B56 complex at the centromere, perhaps
by bridging an interaction with cohesin rings or by helping to preserve centromeric cohesion
(Hara et al., 2014; Liu et al., 2013b).
We next examined whether specific binding to Sgo1 and/or Sgo2 could explain differential B56
isoform localisation. To address this, we artificially relocalized Sgo1 or Sgo2 to the inner kinetochore,
by fusing it to the kinetochore-targeting domain of CENP-B (CB). This location was chosen, even
though it partially overlaps with the endogenous centromeric B56 pool, because it is still accessible
to Aurora B. This may be important because phosphorylation of Sgo2 by Aurora B has been pro-
posed to be needed for B56 interaction (Tanno et al., 2010). Whereas CB-Sgo1 was able to localise
additional B56a and B56g to the inner kinetochore (Figure 2—figure supplement 1), CB-Sgo2 was
only able to recruit additional B56a (Figure 2h–k). To confirm that endogenous Sgo2 displayed
selectivity for specific B56 isoforms, we used a Designed Ankyrin Repeat Protein (DARPin) that can
bind to GFP with high affinity (Brauchle et al., 2014). The DARPin was fused to dCas9 to enable the
selective targeting of YFP-tagged B56a or B56g to a repetitive region on chromosome 7 (Chr7). This
assay confirmed that only B56a, and not B56g , was able to co-recruit endogenous Sgo2 to this
region (Figure 2l,m). Considering Sgo2 is the primary centromeric receptor for B56 (Figure 2a,b)
(Kitajima et al., 2006), this provides an explanation for why only a subset of B56 isoforms localise to
the centromere.
Sgo1 collaborates with BubR1 to recruit B56 to kinetochores
At the kinetochore, PP2A-B56 binds to a phosphorylated LxxIxE motif in BubR1 (Kruse et al., 2013;
Suijkerbuijk et al., 2012; Xu et al., 2013) and this interaction is mediated by a binding pocket on
B56 that is completely conserved in all isoforms (Figure 1—figure supplement 1) (Hertz et al.,
2016; Wang et al., 2016a; Wang et al., 2016b). Therefore, we hypothesised that additional interac-
tions may help to stabilise specific B56 isoforms at the kinetochore. In agreement with this hypothe-
sis, BubR1 depletion or mutation of the LxxIxE binding pocket in B56g (B56gH187A) reduced but did
not completely remove B56g from kinetochores/centromere (Figure 3a–d). This is not due to knock-
down efficiency or penetrance of the mutation, because residual B56 could still be detected after
BubR1 depletion in B56gH187A cells (Figure 3—figure supplement 1a,b). Interestingly, the remaining
B56g in these situations spreads out between the kinetochore and centromere (Figure 3e,f), which
implies that B56g uses additional interactions to be maintained at this region.
Vallardi et al. eLife 2019;8:e42619. DOI: https://doi.org/10.7554/eLife.42619 6 of 25
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Figure 2. Sgo2 specifically localizes B56a to centromeres. (A-G) The effect of Sgo1 and/or Sgo2 knockdown on YFP-B56a localisation in Flp-in HeLa
cells. Representative images (A, C, F) and quantifications (B, D, G) of relative kinetochore intensity of B56a in cells arrested in prometaphase with
nocodazole after knockdown of Sgo2 (A, B), Sgo1 (C, D), or Sgo1 +Sgo2 (F, G). (E) shows line plots of Sgo2 and B56a localisation following Sgo1
knockdown; 5 kinetochore pairs were analysed per cell, for a total of 10 cells per experiment. Graphs represent the mean intensities (±SD) from
3 independent experiments. Intensity is normalized to the maximum signal present in each channel within the endogenous B56a experiment. (H–M)
Flp-in HeLa cells expressing YFP-B56a or YFP-B56g were transfected with the CB-Sgo2 (H–K) or gChr7 +Cas9 DARPIN (L, M) and analysed for B56
recruitment in cells arrested in prometaphase with nocodazole. (H), (L), and J). are representative images; I) and K) are quantifications of relative
centromere/kinetochore intensity of the indicated antigen; and M) is quantification of intensity of Sgo2 over B56 at the Chr7 locus. For all centromere/
kinetochore intensity graphs, each dot represents a cell and 10 cells were quantified per experiment for at least 3 independent experiments. The
spread of dots indicates the biological variation between individual cells and the errors bars display the variation between the experimental repeats
(displayed as -/+SD of the experimental means). Asterisks indicate significance (Mann-Whitney test); ns p>0.05, *p0.05,
****p0.0001. Scale bars, 5mm.
DOI: https://doi.org/10.7554/eLife.42619.009
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A targeted siRNA screen identified critical roles for Knl1 and Bub1, which, when depleted,
completely abolished B56g recruitment to kinetochores (Figure 3—figure supplement 1c–f). Knl1
recruits Bub1 to kinetochores, and Bub1 scaffolds the recruitment of BubR1 (Johnson et al., 2004;
Overlack et al., 2015; Primorac et al., 2013). However, in addition to this, Bub1 also phosphory-
lates histone-H2A to localise Sgo1 to histone tails that are adjacent to the kinetochore (Baron et al.,
2016; Kawashima et al., 2010; Kitajima et al., 2005; Liu et al., 2013a; Tang et al., 2004;
Yamagishi et al., 2010). Since Sgo1 can bind to B56g (Figure 2—figure supplement 1) we exam-
ined its role in the kinetochore recruitment of this isoform. Sgo1 depletion reduced B56gWT at kinet-
ochores and completely removed B56gH187A (Figure 3g,h). Moreover, this was specific for Sgo1,
because Sgo2 depletion had no effect (Figure 3—figure supplement 1g,h). To test whether this
was due to direct binding to Sgo1, we generated a B56g Sgo1-binding mutant (B56gDSgo1), which
we confirmed was defective in binding CB-Sgo1 in vivo (Figure 3—figure supplement 2). This muta-
tion reduced the recruitment of B56gWT to kinetochores and completely abolished the recruitment
of B56gH187A (Figure 3i,j), in a manner that was similar to the effect of Sgo1 depletion (Figure 3g,h).
This demonstrates that Bub1 establishes two separate arms that cooperate to recruit B56g to kineto-
chores: it binds directly to BubR1, which interacts via its LxxIxE motif with B56g , and it phosphory-
lates Histone-H2A to recruit Sgo1, which additionally helps to anchor B56g at kinetochores.
B56 isoforms bind differentially to LxxIxE containing motifs during
mitosis
The B56-Sgo1 interaction is unlikely to explain B56 isoform specificity at kinetochores, since Sgo1
interacts with both B56a and B56g when recruited to centromeres (Figure 2—figure supplement 1).
We therefore focussed on the LxxIxE interaction with BubR1 to quantitatively assess the binding to
B56a and B56g. Immunoprecipitations of equal amounts of B56a and B56g from nocodazole-
arrested cells demonstrated that BubR1 bound preferentially to B56g (Figure 4a,b). Moreover, a
panel of antibodies against other LxxIxE containing proteins (Hertz et al., 2016), demonstrated that
LxxIxE binding was generally reduced in B56a immunoprecipitates (Figure 4a,b). B56g has been
shown to display slightly higher affinities for some LxxIxE containing peptides in vitro (Wu et al.,
2017), which, in principle, could allow this isoform to outcompete B56a for binding. However, a sim-
ple competition model is unlikely to explain differential kinetochore localisation, since we observe
no change in B56a localisation when all other B56 isoforms are present or knocked down (Figure 4c,
d). Instead, we favour the hypothesis that binding to LxxIxE motifs is specifically perturbed in PP2A-
B56a complexes during prometaphase.
Residues within a C-terminal loop of B56 determine localisation to the
centromere or kinetochore
We next searched for the molecular explanation for differential B56 isoform localisation. To do this,
we generated four chimaeras between B56a and B56g by joining the isoforms in the loops that con-
nect the a-helixes (Figure 5a). Immunofluorescence analysis demonstrated that B56g localisation
switched from kinetochores to centromeres in chimaera 4 (Figure 5b,c). Furthermore, this region
alone (i.e. the region that is different between chimaeras 3 and 4) is sufficient to switch localisation
to the centromere when transferred into B56g, and the corresponding region in B56g can induce
localisation to the kinetochore if transplanted into B56a (Figure 5—figure supplement 1). We gen-
erated four additional chimaeras to narrow down this region even further to amino acids 405–425 in
B56a, which contains an a-helix and a small loop that juxtaposes the catalytic domain in the PP2A-
B56g complex (Figure 5d–f) (Xu et al., 2006). Importantly, switching just four amino acids within this
loop in B56a to the corresponding residues in B56g (B56aTKHG) was sufficient to relocalise B56a
from centromeres to kinetochores (Figure 5g–i). Furthermore, the B56aTKHG remained functional
and holoenzyme assembly was unperturbed (Figure 5—figure supplement 2). In summary, a small
Figure 2 continued
The following figure supplement is available for figure 2:
Figure supplement 1. Cenp B-Sgo1 recruits both B56a and B56g to centromeres.
DOI: https://doi.org/10.7554/eLife.42619.010
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Figure 3. BubR1 and Sgo1 localize B56g to kinetochores. B56g kinetochore localisation in Flp-in HeLa cells after BubR1 knockdown (A, B, E) or mutation
of the LxxIxE binding pocket (H187A: C), (D, F) in cells arrested in prometaphase with nocodazole. For each condition, representative images (A, C),
quantification of relative centromere/kinetochore levels (B, D) and line plot analysis (E, F) depicts the levels and distribution of the indicated antigens.
(G–J): representative images (G, I) and quantification of relative centromere/kinetochore intensities (H, J) YFP-B56g WT or H187A following Sgo1
knockdown (G, H) or mutation of the Sgo1 binding region (DSgo1). For all centromere/kinetochore intensity graphs, each dot represents a cell and 10
Figure 3 continued on next page
Vallardi et al. eLife 2019;8:e42619. DOI: https://doi.org/10.7554/eLife.42619 9 of 25
Research article Cell Biology
C-terminal loop in B56 defines whether B56 localises to centromeres, via Sgo2, or to kinetochores,
via an LxxIxE interaction with BubR1.
Figure 3 continued
cells were quantified per experiment from at least 3 independent experiments. The spread of dots indicates the biological variation between individual
cells and the errors bars display the variation between experimental repeats (displayed as -/+SD of the experimental means). For the line plot analysis,
5 kinetochore pairs were analysed per cell, for a total of 10 cells per experiment. The graph represents the mean intensities (±SD) from at least
3 independent experiments. Intensity is normalized to the maximum signal in each channel in each experiment. Asterisks indicate significance (Mann-
Whitney test); ****p0.0001. Scale bars, 5mm.
DOI: https://doi.org/10.7554/eLife.42619.011
The following figure supplements are available for figure 3:
Figure supplement 1. Knl1 and Bub1 depletion completely removes B56g from kinetochores.
DOI: https://doi.org/10.7554/eLife.42619.012
Figure supplement 2. Mutation of the Sgo1 binding region in B56g perturbs binding to CB-Sgo1.
DOI: https://doi.org/10.7554/eLife.42619.013
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Figure 5. A C-terminal loop in B56 specifies B56 localization to centromeres or kinetochores. B56 localisation in B56a-g chimaeras spanning the entire
B56 (Ch1-4: A–C), a region at the C-terminus (Ch4a-4d: D–F). (A, D) Schematic representation of the B56a-g chimaeras created. Representative images
(B, E) and line plot analysis (C, F) to show the B56 localisation pattern in each chimaera. (G). Alignment of B56 isoforms within region 4d that controls
centromere/kinetochore localisation. (G–H): Effect of 4 point-mutations within region 4d to convert B56a to the correspond B56g sequence (B56aTKHG).
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The C-terminal loop controls Sgo2 binding and LxxIxE motif affinity
We next addressed whether the B56aTKHG mutant switched the Sgo2 and LxxIxE binding properties
of B56a. In-cell interaction assays demonstrated that B56aTKHG, in contrast to B56aWT, was not effi-
ciently recruited to the centromere by CB-Sgo2 (Figure 6a,b), and was unable to co-recruit endoge-
nous Sgo2 to the repeat region on chromosome 7, when re-localised there using dCas9-DARPin
(Figure 6c,d). Furthermore, in addition to these effects on Sgo2 interaction, the YFP-B56aTKHG
mutant showed an enhanced ability to bind LxxIxE containing proteins and, in particular, BubR1, fol-
lowing immunoprecipitation from nocodazole-arrested cells (Figure 6e,f). Therefore, we conclude
that the small EPVA loop in B56a is necessary for the interaction with Sgo2 and the centromere and,
in addition, it is also required to fully repress binding to LxxIxE motifs and the kinetochore. Impor-
tantly, this loop is not sufficient to induce either of these effects when transplanted alone into B56g ,
because B56gEPVA is not lost from the kinetochore or gained at the centromere (Figure 6—figure
supplement 1a). Instead, a region immediately C-terminal to the EPVA (amino acids 414–453 in
B56a) is also required to induce centromere binding, and a small helix N-terminal to the EPVA
(amino acids 374–386 in B56a) is needed to repress kinetochore binding (Figure 6—figure supple-
ment 1b). Therefore, although the regions that define centromere and kinetochore localisation over-
lap at the EPVA loop, they have different distal requirements that demonstrates that they are not
identical (Figure 6g).
Discussion
This work demonstrates how different B56 isoforms localise to discrete subcellular compartments to
control separate processes during mitosis. Differential B56 isoform localisation has previously been
observed in interphase (McCright et al., 1996) and during the later stages of mitosis (Bastos et al.,
2014), which implies that B56 isoforms may have evolved to carry out specific functions, at least in
part, by targeting PP2A to distinct subcellular compartments. The differential localisation we observe
during prometaphase arises because B56 isoforms display selectivity for specific receptors at the
centromere and kinetochore.
The centromeric isoform B56a binds preferentially to Sgo2 via a C-terminal stretch that lies
between amino acids 405 and 453 (Figure 6—figure supplement 1). A key loop within this region
juxtaposes the catalytic domain and contains an important EPVA signature that is critical for Sgo2
binding and is unique to B56a and B56e. This sequence is also conserved in Xenopus B56e, which
has previously been shown to selectively bind to Sgo2, when compared to B56g (Rivera et al.,
2012). We therefore propose that a subset of B56 isoforms (B56a and e) utilize unique motifs to
interact with Sgo2 and the centromere during mitosis.
How then can these results be reconciled with the fact that Sgo1 appears to be more important
than Sgo2 for the maintenance of cohesion during mitosis (Huang et al., 2007; Kitajima et al.,
2005; Kitajima et al., 2006; Llano et al., 2008; McGuinness et al., 2005; Rivera et al., 2012;
Tang et al., 2004; Tang et al., 2006; Tanno et al., 2010)? Firstly, it is important to note that Sgo1
can compete with the cohesin release factor, WAPL, for cohesin binding (Hara et al., 2014), thereby
protecting cohesion independently of PP2A. In addition, Sgo1 could help cells to tolerate the loss of
Sgo2, because Sgo2 depletion does not fully remove PP2A-B56 from the centromere, and the pool
that remains under these conditions is dependent on Sgo1 (Figure 2a–g). Therefore, the residual
Sgo1-PP2A-B56a/e that remains at centromeres following Sgo2 depletion could be sufficient to
Figure 5 continued
Representative images (H) and line plot analysis (I) of B56a WT or B56aTKHG in cells arrested in prometaphase with nocodazole. Each graph represents
the mean intensities (±SD) from 3 independent experiments. 5 kinetochore pairs were analysed per cell, for a total of 10 cells per experiment. Intensity
is normalized to the maximum signal in each channel in each experiment. Scale bars, 5mm.
DOI: https://doi.org/10.7554/eLife.42619.015
The following figure supplements are available for figure 5:
Figure supplement 1. Region four is sufficient to induce B56 localization to the centromere or kinetochore.
DOI: https://doi.org/10.7554/eLife.42619.016
Figure supplement 2. Holoenzyme assembly and mitotic exit is unperturbed by B56a TKHG mutation.
DOI: https://doi.org/10.7554/eLife.42619.017
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Figure 6. A C-terminal loop in B56 regulates binding to Sgo2 and LxxIxE motifs to specify centromere/kinetochore localisation. (A-D) Flp-in HeLa cells
expressing either YFP-B56a WT or TKHG were transfected with the CB-Sgo2 and analysed for B56 recruitment (A, B) or gChr7 +dCas9 DARPIN to
assess YFP-B56a:Sgo2 co-localisation (C, D). Representative images (A, C) and quantification of relative kinetochore intensity (B) or intensity of Sgo2
over B56a at the Chr7 locus (D). For the intensity graphs in B) and D), each dot represents a cell and 10 cells were quantified per experiment from at
Figure 6 continued on next page
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preserve cohesion. Finally, Sgo1 is needed to preserve Sgo2-PP2A-B56 at the centromere
(Figure 2e) and it can also bind directly to the SA2–Scc1 complex (Hara et al., 2014; Liu et al.,
2013b; Tanno et al., 2010). Therefore, perhaps Sgo1 also helps to position Sgo2-PP2A-B56 so that
it can dephosphorylate nearby residues within the cohesin complex. It will be important in future to
examine the interplay between Sgo1, Sgo2 and PP2A-B56 at centromeres.
The kinetochore B56 isoforms bind to BubR1 via a canonical LxxIxE motif within the KARD
(Hertz et al., 2016; Kruse et al., 2013; Suijkerbuijk et al., 2012; Xu et al., 2013). Although the
LxxIxE binding pocket is completely conserved in all B56 isoforms (Figure 1—figure supplement 1),
we observe a striking preference in the binding of B56g over B56a to many LxxIxE containing pro-
teins during prometaphase (Figure 4). We hypothesise that this is due to repressed binding between
LxxIxE motifs and B56a during prometaphase, because LxxIxE binding (Figure 6e,f) and kinetochore
accumulation (Figure 5h,j) can both be enhanced by mutation of the EPVA loop in B56a (B56aTKHG).
We cannot, however, exclude the possibility that the corresponding TKHG sequence in B56g posi-
tively regulates LxxIxE interaction and kinetochore localisation. Considering that this region also con-
trols Sgo2 and centromere binding, a simple explanation could be that Sgo2 interaction obscures
the LxxIxE binding pocket. However, this appears unlikely for four reasons: 1) Sgo2 depletion does
not relocalise B56a to kinetochores (Figure 2a,b), 2) Sgo2 depletion does not enhance the ability of
B56a to bind to BubR1 or other LxxIxE motifs during mitosis (Figure 6—figure supplement 2), 3)
centromere and kinetochore binding can occur together in certain B56a-g chimaeras (Figure 6—fig-
ure supplement 1b), and 4) the regions that define each of these localisations do not fully overlap
(Figure 6g). Although we believe these results imply that Sgo2 is unlikely to block LxxIxE interaction,
in vitro experiments with purified components would ultimately be needed to formally rule this out.
If not Sgo2, then what could limit the kinetochore accumulation of B56a? We speculate that another
interacting partner, or alternatively a tail region within a PP2A-B56 subunit, might obscure or modify
the conformation of the LxxIxE binding pocket in PP2A-B56a complexes.
An important additional finding of this work is that Sgo1 contributes to the B56g signal observed
at the kinetochore (Figure 3g–j). This likely requires Sgo1 to be bound to histone tails, because it
also depends on Bub1, the kinase that phosphorylates histone H2A to recruit Sgo1 (Baron et al.,
2016; Kawashima et al., 2010; Kitajima et al., 2005; Liu et al., 2013a; Tang et al., 2004;
Yamagishi et al., 2010) (Figure 3—figure supplement 1). It is not currently clear whether a Sgo1:
PP2A-B56g complex simply contributes to the signal observed at kinetochores or whether it may
help to physically retain BubR1:PP2A-B56 at the kinetochore, for example, by directly interacting
with the BubR1:PP2A-B56 complex. The interfaces between BubR1-B56 and Sgo1-PP2A-B56 do not
appear to be overlapping, at least based on current structural data (Wang et al., 2016a;
Wang et al., 2016b; Xu et al., 2009), which implies that Knl1-bound BubR1-B56 could potentially
be anchored towards histone tails by Sgo1. We were unable to detect Sgo1 in YFP-BubR1 immuno-
precipitates (results not shown), however, this could simply reflect an interaction that is either tran-
sient or unstable away from kinetochores. It will be important in future to clarify exactly how Sgo1
Figure 6 continued
least 3 independent experiments. The spread of dots indicates the biological variation between individual cells and the errors bars display the variation
between experimental repeats (displayed as -/+SD of the experimental means). (E) Immunoblot of the indicated antigens following
immunoprecipitation of YFP from nocodazole-arrested Flp-in HeLa cells expressing YFP- B56g , YFP-B56a WT or YFP-B56a-TKHG. (F) Quantification of
the mean normalised intensity (+SD) of indicated antigens in B56a WT or B56a TKHG immunoprecipitates, relative to B56g , from at least
4 experiments. (G) Crystal structure of PP2A-B56g [accession code 2NPP (Xu et al., 2006)] with annotation to indicate the regions that specify
localisation to centromeres or kinetochores (see Figure 6—figure supplement 1 for details of the additional centromere/kinetochore specification
regions). Note, the structure is meant only as a guide because the critical regions may be present within B56a, which has not been structurally solved.
The B56a WT values are also used in some of the points plotted in Figure 2m. Asterisks indicate significance (Mann-Whitney test, except Figure 6f:
Welch’s t -test, unpaired); ns p>0.05, *p0.05, **p0.01, ***p0.001, ****p0.0001. Scale bars, 5mm.
DOI: https://doi.org/10.7554/eLife.42619.018
The following figure supplements are available for figure 6:
Figure supplement 1. Additional residues from B56a are required to switch the localisation of B56g.
DOI: https://doi.org/10.7554/eLife.42619.019
Figure supplement 2. Sgo2 depletion does not enhance the ability of B56a to bind BubR1 or LxxIxE motifs.
DOI: https://doi.org/10.7554/eLife.42619.020
Vallardi et al. eLife 2019;8:e42619. DOI: https://doi.org/10.7554/eLife.42619 14 of 25
Research article Cell Biology
collaborates with BubR1 to control B56 localisation and, in particular, to determine whether Sgo1
can interact with BubR1:PP2A-B56 complexes directly. If such a complex can exist, then this could
have important implications for SAC signalling and tension-sensing.
In summary, the work presented here explains how different members of the PP2A-B56 family
function during the same stage of mitosis to control different biological processes. This is the first
time that such sub-functionalisation has been demonstrated between isoforms of the same B family.
It is currently unclear why such specialisation is necessary or at least preferable to a situation
whereby all B56 isoforms operate redundantly, as initially suggested (Foley et al., 2011). One possi-
bility is that the use of different B56 isoforms allows PP2A catalytic activity to be regulated differ-
ently in specific subcellular compartments: for example, by enabling interactions or post-
translational modifications that are specific for the B56 subunits. In this respect, protein inhibitors of
PP2A-B56 have been shown to function specifically at the centromere (SET (Chambon et al., 2013))
and at the kinetochore (BOD1 (Porter et al., 2013)); therefore, it would be interesting to test
whether these inhibitors display selectivity for certain PP2A-B56 isoforms. Future studies such as
this, which build upon the work presented here, may ultimately help to reveal novel ways to modu-
late the activity of specific PP2A-B56 complexes. The recent development of selective inhibitors of
related PP1 regulatory isoforms to combat neurodegenerative diseases (Das et al., 2015;
Krzyzosiak et al., 2018), provides a proof-of-concept that successful targeting of specific serine/
threonine phosphatase isoforms is both achievable and therapeutically valuable.
Materials and methods
Key resources table
Reagent type
or resource Designation Source or reference Identifiers Additional information
Cell line
(H.sapiens)
HeLa Flp-in Tighe et al. (2008)
Recombinant
DNA reagent
pcDNA5-YFP-B56
a, b, g1, g3, d and e.
This paper B56 from pCEP-4xHA-B56
(Addgene 14532–14537) cloned
into pcDNA5-LAP-BubR1WT
(Nijenhuis et al., 2014),
Not1-Apa1 sites.
Recombinant DNA
reagent
pcDNA5-YFP-B56a (TKHG) This paper Site-directed mutagenesis of
pcDNA5-YFP-B56a: E405T, P409K,
V412H, A413G
Recombinant DNA
reagent
pcDNA5-YFP-B56a-(g4) This paper See
Figure 5—figure supplement 1
Recombinant DNA
reagent
pcDNA5-YFP-B56g-H187A This paper Site-directed mutagenesis
of pcDNA5-YFP-B56g
Recombinant DNA
reagent
pcDNA5-YFP-B56g-DSgo1 This paper Site-directed mutagenesis of
pcDNA5-YFP-B56g : Y391F, L394S,
M398Q.
Recombinant DNA
reagent
pcDNA5-YFP-B56g-H187A-DSgo1 This paper Site-directed mutagenesis of
pcDNA5-YFP-B56g-H187A: Y391F,
L394S, M398Q.
Recombinant DNA
reagent
pcDNA5-YFP-B56g-(a4) This paper See
Figure 5—figure supplement 1
Recombinant DNA
reagent
pcDNA5-YFP-B56g-(a4.1) This paper See
Figure 6—figure supplement 1
Recombinant DNA
reagent
pcDNA5-YFP-B56g-(a4.2) This paper See
Figure 6—figure supplement 1
Recombinant DNA
reagent
pcDNA5-YFP-B56g-(a4.3) This paper See
Figure 6—figure supplement 1
Recombinant DNA
reagent
pcDNA5-YFP-B56g (EPVA) This paper Site-directed mutagenesis of
pcDNA5-YFP-B56g : T631E, K635P,
H638V, G639A.
Continued on next page
Vallardi et al. eLife 2019;8:e42619. DOI: https://doi.org/10.7554/eLife.42619 15 of 25
Research article Cell Biology
Continued
Reagent type
or resource Designation Source or reference Identifiers Additional information
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch1 This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch2 This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch3 This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch4 This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch4a This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch4b This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch4c This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-YFP-B56-Ch4d This paper See Figure 5.
Recombinant DNA
reagent
pcDNA5-vsv-CENP-
B-Sgo2-mCherry
This paper PCR Sgo2 from pDONR-Sgo2
(gift T.J.Yen) into pcDNA5-vsv-
CENP-B-Sgo1-mCherry
Recombinant DNA
reagent
pcDNA5-vsv-CENP-B-
Sgo1-mCherry
Meppelink et al. (2015)
Recombinant DNA
reagent
pHAGE-TO-dCas9-
DARPIN-flag
This paper Progenitor plasmid: pHAGE-TO-
dCas9-3xmCherry (Addgene
64108). 3xmCherry replaced with
synthesised DARPIN-Flag
(Brauchle et al., 2014).
Sequence-based
reagent
gRNA targeting a
repetetive region on
chromosome 7
Chen et al. (2016) GCTCTTATGGTGAGAGTGT
Sequence-based
reagent
B56 Knockin gRNAs This paper B56a: gatgtcgtcgtcgtcgccgccgg.
B56g: gtcaacatctagacttcagcggg
Sequence-based
reagent
siRNAs Foley et al. (2011) B56a (PPP2R5A),
5’-UGAAUGAACUGGUUGAGUA-3’;
B56b (PPP2R5B),
5’-GAACAAUGAGUAUAUCCUA-3’;
B56g (PPP2R5C),
5’-GGAAGAUGAACCAACGUUA-3’;
B56d (PPP2R5D),
5’-UGACUGAGCCGGUAAUUGU-3’;
B56e (PPP2R5E),
5’-GCACAGCUGGCAUAUUGUA-3’;
Sequence-based
reagent
siRNAs Kitajima et al. (2006) Sgo2,
5’-GCACUACCACUUUGAAUAA-3’;
Sequence-based
reagent
siRNAs Dharmacon, J-015475–12 Sgo1,
5’-GAUGACAGCUCCAGAAAUU-3’;
Sequence-based
reagent
siRNAs Nijenhuis et al. (2014) BubR1,
5’-AGAUCCUGGCUAACUGUUC-3’
Sequence-based
reagent
siRNAs Vleugel et al. (2013) Knl1,
5’-GCAUGUAUCUCUUAAGGAA-3’;
Bub1
5’-GAAUGUAAGCGUUCACGAA-3’;
Sequence-based
reagent
siRNAs Dharmacon (D-001830) Control (GAPDH),
5’-GUCAACGGAUUUGGUCGUA-3’
Antibody Mouse monoclonal
anti-GFP (clone 4E12/8)
Peter Parker, Francis
Crick Institute
1:1000
Continued on next page
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Continued
Reagent type
or resource Designation Source or reference Identifiers Additional information
Antibody Chicken polyclonal
anti-GFP
Abcam Abcam: ab13970,
RRID:AB_300798
1:5000
Antibody Mouse monoclonal
anti-Sgo1 (clone 3C11)
Abnova Abnova:
H001516480M01
1:1000
Antibody Rabbit polyclonal
anti-Sgo2
Bethyl Bethyl:
A301-262A,
RRID:AB_890650
1:1000
Antibody Mouse monoclonal
anti-BubR1 (clone 8G1)
EMD Millipore EMD Millipore:
05–898,
RRID:AB_417374
1:1000
Antibody Mouse monoclonal
anti-VSV (clone P5D4)
Sigma Sigma: V5507,
RRID:AB_261877
1:1000
Antibody Rabbit polyclonal
anti-Knl1
Abcam Abcam:
ab70537,
RRID:AB_1209410
1:1000
Antibody Rabbit polyclonal
anti-Bub1
Bethyl Bethy;l:
A300-373A,
RRID:AB_2065943
1:1000
Antibody Mouse monoclonal
anti-FLAG (clone M2)
Sigma Sigma: F3165,
RRID:AB_259529
1:10000
Antibody Guinea Pig polyclonal
anti-Cenp-C
MBL MBL: PD030 1:5000
Antibody Rabbit polyclonal
anti-pMELT-Knl1
(phospho-T943 and -
T1155)
Nijenhuis et al. (2014) 1:1000
Antibody Rabbit polyclonal
anti-GFP
Geert Kops, Hubrecht
Institute
1:5000
Antibody Mouse monoclonal
anti-B56g (clone A-11)
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology:
sc-374379,
RRID:AB_10988028
1:1000
Antibody Mouse monoclonal
anti-B56a (clone 23)
BD Biosciences BD Biosciences:
610615,
RRID:AB_397947
1:1000
Antibody Mouse monoclonal
anti-B56d (clone H-11)
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology:
sc-271363,
RRID:AB_10611062
1:1000
Antibody Rabbit polyclonal
anti-B56e
Aviva Aviva:
ARP56694-P50
1:1000
Antibody Mouse monoclonal
anti-PPP2CA
(clone 1D6)
EMD Millipore EMD Millipore:
05–421,
RRID:AB_309726
1:5000
Antibody Rabbit polyclonal
anti-PPP2R1A
(clone 81G5)
Cell Signaling
Technology
Cell Signaling
Technology: 2041,
RRID:AB_2168121
1:1000
Antibody Rabbit polyclonal
anti-BubR1
Bethyl Bethyl:
A300-386A,
RRID:AB_386097
1:1000
Antibody Rabbit polyclonal
anti-Axin
Cell Signaling
Technology
Cell Signaling
Technology: C76H11,
RRID:AB_2274550
1:1000
Antibody Rabbit polyclonal
anti-GEF-H1
Abcam Abcam: ab155785 1:1000
Continued on next page
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Continued
Reagent type
or resource Designation Source or reference Identifiers Additional information
Antibody Rabbit polyclonal
anti-Kif4A
Bethyl Bethyl: A301-074A,
RRID:AB_2280904
1:1000
Antibody Rabbit polyclonal
anti-Repoman
Sigma Sigma: HPA030049,
RRID:AB_10600862
1:1000
Antibody Rabbit polyclonal
anti-Actin
Sigma Sigma: A2066,
RRID:AB_476693
1:5000
Antibody Mouse monoclonal
anti-a-Tubulin
(clone B-5-1-2)
Sigma Sigma: T5168,
RRID:AB_477579
1:5000
Antibody Alexa-fluor488
anti-mouse
ThermoFisher
Scientific
Invitrogen: A11029,
RRID:AB_138404
1:1000
Antibody Alexa-fluor488
anti-rabbit
ThermoFisher
Scientific
Invitrogen: A11034,
RRID:AB_2576217
1:1000
Antibody Alexa-fluor488
anti-chicken
ThermoFisher
Scientific
Invitrogen: A11039,
RRID:AB_142924
1:1000
Antibody Alexa-fluor488
anti-guinea pig
ThermoFisher
Scientific
Invitrogen: A11073,
RRID:AB_142018
1:1000
Antibody Alexa-fluor568
anti-mouse
ThermoFisher
Scientific
Invitrogen: A11031,
RRID:AB_144696
1:1000
Antibody Alexa-fluor568
anti-rabbit
ThermoFisher
Scientific
Invitrogen: A11036,
RRID:AB_10563566
1:1000
Antibody Alexa-fluor647
anti-guinea pig
ThermoFisher
Scientific
Invitrogen: A21450,
RRID:AB_141882
1:1000
Antibody HRP-anti-mouse Bio-Rad Bio-Rad: 170–6516,
RRID:AB_11125547
1:2000
Antibody HRP-anti-rabbit Bio-Rad Bio-Rad: 170–6515,
RRID:AB_11125142
1:5000
Chemical
compound, drug
AZ-3146 Selleckchem Selleckchem: S2731
Chemical
compound, drug
Calyculin A LC labs LC labs: C-3987
Chemical
compound, drug
4,6-diamidino-2-
phenylindole (DAPI)
Sigma Roche: 10236276001
Chemical
compound, drug
Dulbecco’s Modified
Eagle Medium (DMEM)
ThermoFisher
Scientific
Gibco: 41966029
Chemical
compound, drug
Doxycycline hyclate Sigma Sigma: D9891
Chemical
compound, drug
Fetal Bovine Serum ThermoFisher
Scientific
Life Technologies:
10270106
Chemical
compound, drug
GFP-Trap magnetic
beads
Chromotek Chromotek: GTMA-20
Chemical
compound, drug
Hygromycin B Santa Cruz
Biotechnology
Santa Cruz
Biotechnology:
sc-29067
Chemical
compound, drug
Lipofectamine
RNAiMax
ThermoFisher
Scientific
Invitrogen: 13778150
Chemical
compound, drug
Nocodazole EMD Millipore EMD Millipore: 487928
Chemical
compound, drug
MG132 Selleckcem Selleckchem: S2619
Chemical
compound, drug
Opti-MEM reduced
serum medium
ThermoFisher
Scientific
Gibco: 31985–047
Continued on next page
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Continued
Reagent type
or resource Designation Source or reference Identifiers Additional information
Chemical
compound, drug
penicillin/streptomycin ThermoFisher
Scientific
Gibco: 15070–063
Chemical
compound, drug
RO-3306 Tocris Tocris: 4181
Chemical
compound, drug
Thymidine Sigma Sigma: T1895
Software,
algorithm
Kinetochore quantification
macro
Saurin et al. (2011) Software,
Algorithm Multicolor Line
plot quantification
macro
Kees Straatman (University
of Leicester) with modification
by Balaji Ramalingam
(University of Dundee)
Software,
algorithm
Quantification of
immunoblots
Image Studio Lite
(LI-COR Biosciences)
Software,
algorithm
Microscopy image
processing
Softworx software,
GE Healthcare
Software,
algorithm
Microscopy image
processing
ImageJ, National
Institutes of Health
Cell culture and reagents
HeLa Flp-in cells (Tighe et al., 2008), stably expressing a TetR, were authenticated by STR profiling
(Eurofins) and cultured in DMEM supplemented with 9% tetracycline-free FBS, 50 mg/mL penicillin/
streptomycin and 2 mM L-glutamine. All cell lines were routinely screened (every 4–8 weeks) to
ensure they were free from mycoplasma contamination. All HeLa Flp-in cells stably expressing a
doxycycline-inducible construct were derived from the HeLa Flp-in cell line by transfection with the
pCDNA5/FRT/TO vector (Invitrogen) and the FLP recombinase, pOG44 (Invitrogen), and cultured in
the same medium but containing 200 mg/mL hygromycin-B. Plasmids were transfected using Fugene
HD (Promega) according to manufacturer’s protocol. 1 mg/mL doxycycline was added for 16 hr to
induce protein expression in the inducible cell lines. Thymidine (2 mM) and nocodazole (3.3 mM)
were purchased from Millipore, MG132 (10 mM) and AZ-3146 from Selleck Chemicals, doxycycline (1
mg/mL) from Sigma, 4,6- diamidino-2-phenylindole (DAPI, 1:50000) from Invitrogen, calyculin A (10
mM in 10% EtOH) from LC labs, RO-3306 (10 mM) from Tocris and hygromycin-B from Santa Cruz
Biotechnology.
Plasmids and cloning
pCDNA5-YFP -B56a, b, g1, g3, d and e were amplified from pCEP-4xHA-B56 (Addgene plasmids
14532–14537; deposited by D. Virshup, Duke-NUS Graduate Medical School, Singapore) and subcl-
oned into pCDNA5-LAP-BubR1WT (Nijenhuis et al., 2014) through Not1 and Apa1 restriction sites.
B56g1 and B56g3 were corrected to start on M1 and not 11, and the R494L mutation in B56g3 was
corrected. pCDNA5-YFP-B56a and pCDNA5-YFP-B56g1 were made siRNA-resistant by site-directed
mutagenesis (silent mutations in the coding sequence for E102 and L103 in B56a, and T126 and
L127 in B56g). All B56a and B56g1 mutants were created by site-directed mutagenesis from
pCDNA5-YFP-B56a and pCDNA5-YFP-B56g1, respectively. The B56a–g chimeras were generated by
Gibson assembly with pCDNA5-YFP-B56a and pCDNA5-YFP-B56g used as templates for the PCR
reaction. vsv-CENP-B-Sgo1-mCherry (Meppelink et al., 2015) was used to make vsv-CENP-B-Sgo2-
mCherry, by removing Sgo1 and adding Sgo2 via Gibson assembly from pDONR-Sgo2 (a gift from
T. J. Yen). The Sgo1 binding mutant in B56g (B56g DSgo1) was created by site directed mutagenesis
to create three mutations: Y391F, L394S and M398Q. The dCas9-DARPIN-flag was created by
digesting pHAGE-TO-dCas9-3xmCherry (Addgene #64108) with BamHI and XhoI to remove
3xmCherry and replace with a synthesised DARPIN-flag that binds to GFP with high affinity
(Brauchle et al., 2014). The gRNA targeting a repetitive region on chromosome seven was gener-
ated by PCR mutagenesis to introduce the gRNA sequence (GCTCTTATGGTGAGAGTGT
(Chen et al., 2016)) into the pU6 vector.
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Gene knockdowns
Cells were transfected with 20 nM siRNA using Lipofectamine RNAiMAX Transfection Reagent (Life
Technologies) according to the manufacturer’s instructions. For simultaneous knockdown of all B56
isoforms (B56pool) the single B56 isoform siRNA were mixed at equimolar ratio of 20 nM each. The
siRNA sequences used in this study are as follows: B56a (PPP2R5A), 5’-UGAAUGAACUGGUUGAG
UA-3’; B56b (PPP2R5B), 5’-GAACAAUGAGUAUAUCCUA-3’; B56g (PPP2R5C), 5’-GGAAGAUGAAC-
CAACGUUA-3’; B56d (PPP2R5D), 5’-UGACUGAGCCGGUAAUUGU-3’; B56e (PPP2R5E), 5’-GCA-
CAGCUGGCAUAUUGUA-3’; Sgo1, 5’-GAUGACAGCUCCAGAAAUU-3’; Sgo2, 5’-GCACUACCAC
UUUGAAUAA-3’; BubR1, 5’-AGAUCCUGGCUAACUGUUC-3’; Knl1, 5’-GCAUGUAUCUCUUAAG-
GAA-3’; Bub1 5’-GAAUGUAAGCGUUCACGAA-3’; Control (GAPDH), 5’-GUCAACGGAUUUGGUCG
UA-3’;. All siRNA oligos were custom made and purchased from Sigma, except for Sgo1, which was
ordered from Dharmacon (J-015475–12).
Expression of B56 isoforms
For reconstitution of B56 isoforms or mutants, HeLa Flp-in cells were transfected with 100 nM
B56pool or mock siRNA and, in some experiments, 20 nM additional control, Sgo1, Sgo2, BubR1,
Bub1 or Knl1 siRNA. Cells were transfected with the appropriate siRNA for 16 hr, after which they
were arrested in S phase for 24 hr by addition of thymidine. Subsequently, cells were released from
thymidine for 8–10 hr and arrested in prometaphase by the addition of nocodazole. YFP-B56 expres-
sion was induced by the addition of doxycycline during and following the thymidine block. For
BubR1 knockdowns and for all chromosome alignment assays, cells were released from thymidine
for 6.5 hr and arrested at the G2/M boundary with RO3306 for 2 hr. Cells were then released into
nocodazole (BubR1 experiments) or normal growth media (alignment assays) for 15 mins before
MG132 was then added for 30 mins to prevent mitotic exit. For alignment assays, this is critical to
analyse the synchronous alignment of mitotic cells over a 45 min period.
Chromosome spreads to analyse centromeric cohesion
Hela-FRT cells were transfected with B56pool, B56bgde, B56agde or control siRNA for 16 hr, treated
with thymidine for 24 hr and released into normal growth media for 6.5 hr. Cells were then arrested
at the G2/M boundary with RO3306 for 2 hr before release into nocodazole for 1 hr. Mitotic cells
were isolated and incubated with hypotonic buffer (20 mM Hepes (pH7.0), 1 mM MgCl2, 20 mM
KCl, 2 mM CaCl2) for 10 min at room temperature before being spun onto slides using a Cellspin
cytocentrifuge (Tharmac). Slides were airdried for 1 min and then fixed in 4% formaldehyde in PBS
for 10 min at room temperature. Blocking and immunofluorescence staining (for Cenp-C to visualise
split kinetochore pairs) was carried out as described below. The percentage of cells with at least one
split sister kinetochore pair was quantified.
In-cell protein-protein interaction assay using dCas9 or CB-Sgo1/2
Cells were transfected with dCas9-DARPIN-flag and a guide RNA that targets a repetitive region on
chromosome 7 (at 1:3 ratio of dCas9:gRNA). Doxycycline was added to induce YFP-B56 isoform
expression and 48 hr later cells arrested in mitosis with nocodazole were fixed, stained and imaged
for co-localisation of YFP-B56 isoforms and Sgo2. Only cells containing defined Flag-dCas9 spots
that also co-recruited YFP-B56 were imaged. The majority of these spots recruited YFP-B56, but the
dCas9 spots themselves were only readily detectable in mitotic cells. For the CB-Sgo1/2 expression
experiments, the endogenous Sgo1/2 was still present during these assays.
CRISPR/Cas9 knock-in
800 base pair homology arms that span left and right of the start codon of B56a and B56g were cus-
tom synthetized by Biomatik. A NaeI (B56g)/SwaI (B56a) restriction site was place between the
homology arms and used to insert a YFP tag by Gibson assembly. Guides were designed to span
the start codon (using http://crispr.mit.edu/) so that their complementary sequences are interrupted
following successful homologous recombination. Flp-in HeLa Cas9 cells were generated and trans-
fected with the YFP-homology arm vector and guide RNAs (B56a: gatgtcgtcgtcgtcgccgccgg B56g:
gtcaacatctagacttcagcggg) in a 1:1 ratio. Cas9 expression was then induced by addition of
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doxycycline and FACS was performed 2 weeks later to sort cells and enrich for the YFP-expressing
population.
Live-cell imaging and immunofluorescence
For time-lapse analysis, cells were plated in 24-well plates, transfected and imaged in a heated
chamber (37˚C and 5% CO2) using a 10x/0.5 NA on a Zeiss Axiovert 200M Imaging system, con-
trolled by Micro-manager software (open source: https://www.micro-manager.org/). Images were
acquired with a Hamamatsu ORCA-ER camera every 4 min using 2  2 binning. For immunofluores-
cence, cells were plated on High Precision 1.5H 12 mm coverslips (Marienfeld). Following the appro-
priate treatment, cells were pre-extracted with 0.1% Triton X-100 in PEM (100 mM Pipes, pH 6.8, 1
mM MgCl2 and 5 mM EGTA) for 1 min followed by addition of 4% PFA/PBS for 2 min; cells were
subsequently fixed with 4% paraformaldehyde in PBS for 10 min. Coverslips were washed with PBS
and blocked with 3% BSA in PBS + 0.5% Triton X-100 for 30 min, incubated with primary antibodies
for 16 hr at 4˚C, washed three times with PBS and incubated with secondary antibodies plus DAPI
for an additional 2–4 hr at room temperature in the dark. Washed coverslips were then mounted on
a glass slide using ProLong antifade reagent (Molecular Probes). All images were acquired on a Del-
taVision Core or Elite system equipped with a heated 37˚C chamber, with a 100x/1.40 NA U Plan S
Apochromat objective using softWoRx software (Applied precision). Images were acquired at 1  1
binning using a CoolSNAP HQ2 camera (Photometrics) and processed using softWorx software and
ImageJ (National Institutes of Health). All images displayed are maximum intensity projections of
deconvolved stacks. All displayed immunofluorescence images were chosen to most closely repre-
sent the mean quantified data.
Image quantifications
For kinetochore quantification of immunostainings, all images within an experiment were acquired
with identical illumination settings and analysed using ImageJ (for experiments in which ectopic pro-
teins were expressed, cells with comparable levels of exogenous protein were selected for analysis).
Kinetochore quantification was performed as previously (Saurin et al., 2011). For quantification of
B56 localization, The Cenp-C channel was used to choose 5 random kinetochore pairs per cell that
lie on the same 0.2 mm Z-plane. A line was then drawn through the kinetochore pairs (using ImageJ),
with the first Cenp-C kinetochore peak at 0.2 mm from the start of the line. An ImageJ macro (cre-
ated by Kees Straatman, University of Leicester and modified by Balaji Ramalingam, University of
Dundee) was used to simultaneously measure the intensities in each channel across the line. The sig-
nal from the five kinetochore pairs was averaged and normalized to the maximum signal in each
channel. For chromosome alignment assays, misalignments were score as mild (1 to 2 misaligned
chromosomes), intermediate (3 to 5 misaligned chromosomes), and severe (>5 misaligned chromo-
somes). For mitotic exit assays, time from entry into mitosis (defined by the rounding up of the cell)
to mitotic exit (defined by the separation of the sister chromatids or flattening down of the cell in
nocodazole +AZ-3146) were recorded for 50 cells. Data is presented as cumulative percentage of
mitotic exit over time.
Immunoprecipitation and immunoblotting
Flp-in HeLa cells were treated with thymidine and doxycycline for 24 hr and subsequently released
into fresh media supplemented with doxycycline and nocodazole for 16 hr. Mitotic cells were iso-
lated by mitotic shake off and lysed in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.5% TX-100,
1 mM Na3VO4, 5 mM ß-glycerophosphate, 25 mM NaF, 10 nM Calyculin A and complete protease
inhibitor containing EDTA (Roche)) on ice. The lysate was incubated with GFP-Trap magnetic beads
(from ChromoTek) for 2 hr at 4˚C on a rotating wheel in wash buffer (same as lysis Buffer, but with-
out TX-100) at a 3:2 ratio of wash buffer:lysate. The beads were washed 3x with wash buffer and the
sample was eluted according to the protocol from ChromoTek. Samples were them processed for
SDS-Page and immunoblotting using standard protocols.
Quantification of immunoblots
For quantification of relative immunoprecipitation levels, scanned immunoblots were analyzed using
Image Studio Lite (LI-COR Bioscences). A rectangle of the same size was drawn around each band
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and the intensity within the band (minus the background) was calculated. The immunoprecipitated
protein was used as a control, and each band was normalized to it.
Antibodies
All antibodies were diluted in 3% BSA in PBS. The following primary antibodies were used for immu-
nofluorescence imaging (at the final concentration indicated): mouse a-GFP (clone 4E12/8, a gift
from P. Parker; 1:1000), chicken a-GFP (ab13970, Abcam; 1:5000), mouse a- Sgo1 (clone 3C11,
H00151648-M01, Abnova; 1:1000), rabbit a-Sgo2 (A301-262A, Bethyl; 1:1000), mouse a-BubR1
(clone 8G1, 05–898, Upstate/Millipore; 1:1000), mouse a-VSV (clone P5D4, V5507, Sigma; 1:1000),
rabbit a-Knl1 (ab70537, Abcam; 1:1000), rabbit a-Bub1 (A300-373A, Bethyl; 1:1000), mouse a-FLAG
(clone M2, F3165, Sigma, 1:10000) guinea pig a-Cenp-C (PD030, MBL; 1:5000) and rabbit a-pMELT-
Knl1 directed against T943 and T1155 of human Knl1 (Nijenhuis et al., 2014), 1:1000). Secondary
antibodies used were highly-cross absorbed goat a-rabbit, a-mouse, a-guinea pig or a-chicken cou-
pled to Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (Life Technologies); all were used at
1:1000.
The following antibodies were used for western blotting (at the final concentration indicated):
rabbit a-GFP (custom polyclonal, a gift from G. Kops; 1:5000), mouse a-B56g (clone A-11, sc-
374379, Santa Cruz Biotechnology; 1:1000), mouse a-B56a (clone 23, 610615, BD; 1:1000), mouse
a-B56d (clone H-11, sc-271363, Santa Cruz, 1:1000), rabbit a-B56e (ARP56694-P050, Aviva, 1:1000),
mouse a-PPP2CA (clone 1D6, 05–421, Millipore; 1:5000) and rabbit a-PPP2R1A (clone 81G5, #2041,
CST; 1:1000), rabbit a-BubR1 (A300-386A, Bethyl; 1:1000), rabbit a-Axin (C76H11, CST; 1:1000),
rabbit a-GEF-H1 (155785, Abcam; 1:1000), rabbit a-Kif4a (A301-074A, Bethyl; 1:1000), rabbit a-
RepoMan (HPA030049, Sigma; 1:1000) and rabbit a-Actin (A2066, Sigma; 1:5000) and mouse a-
alpha-Tubulin (clone B-5-1-2, T5168, Sigma, 1:5000). Secondary antibodies used were goat a-mouse
IgG HRP conjugate (Bio-Rad; 1:2000) and goat a-rabbit IgG HRP conjugate (Bio-Rad; 1:5000).
Statistical tests
Mann-Whitney U test was performed to compare experimental groups in all kinetochore/centromere
quantification graphs, whereas two-tailed, unpaired t-test with Welch’s correction was performed to
compare experimental groups in all other graphs (using Prism seven software). The n numbers for
kinetochore/centromere quantification statistics were derived from the individual cells (i.e. biological
replicates), which were always from at least three separate experiments (i.e. technical replicates)
with similar results. The n numbers for the statistics in all other graphs were defined by the number
of experimental repeats. The SD bars displayed in each graph shows the variation between the
means of the experimental repeats. The statistical comparisons most pertinent for the conclusions
are shown in the figures and legends. The original data for all experiments displayed in graphs can
be found in the raw data source file, which also contains the actual statistical values.
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